CIK 0001610853 · Non-accelerated filer<br>Smaller reporting company
Solana Co
Sign in to watch- Ticker
- HSDT
- Exchange
- Nasdaq
- Industry
- Finance Services
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364787690
- Phone
- 215-944-6100
- Business address
- 1650 MARKET STREET, SUITE 3600, PHILADELPHIA, PA, 19103
- Former names
- HELIUS MEDICAL TECHNOLOGIES, INC., HELIUS MEDICAL TECHNOLOGIES, INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 87 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-11-30 | ANDREEFF DANE President and CEO | Purchase | +641 | $6.37 | $4K | 10,633 |
| 2023-08-30 | ANDREEFF DANE President and CEO | Purchase | +2,646 | $7.64 | $20K | 11,420 |
| 2023-08-30 | ANDREEFF DANE President and CEO | Purchase | +555 | $7.64 | $4K | 2,375 |
| 2023-08-30 | ANDREEFF DANE President and CEO | Purchase | +1,658 | $7.64 | $13K | 9,992 |
| 2023-08-30 | ANDREEFF DANE President and CEO | Purchase | +141 | $7.64 | $1K | 599 |
| 2023-08-28 | ANDREEFF DANE President and CEO | Purchase | +2,688 | $6.37 | $17K | 8,774 |
| 2023-08-28 | ANDREEFF DANE President and CEO | Purchase | +563 | $6.37 | $4K | 1,820 |
| 2023-08-28 | ANDREEFF DANE President and CEO | Purchase | +1,684 | $6.37 | $11K | 8,334 |
| 2023-08-28 | ANDREEFF DANE President and CEO | Purchase | +143 | $6.37 | $911 | 458 |
| 2023-05-24 | STRAW EDWARD M Director | Grant or award | +83,054 | 90,111 | ||
| 2023-05-24 | STRAW EDWARD M Director | Grant or award · Stock Option (Right to Buy) | +284,865 | 284,865 | ||
| 2023-05-24 | BUCKMAN PAUL Director | Grant or award | +83,054 | 89,824 | ||
| 2023-05-24 | BUCKMAN PAUL Director | Grant or award · Stock Option (Right to Buy) | +284,865 | 284,865 | ||
| 2023-05-24 | Perkins Sherrie L Director | Grant or award | +83,054 | 90,040 | ||
| 2023-05-24 | Perkins Sherrie L Director | Grant or award · Stock Option (Right to Buy) | +284,865 | 284,865 | ||
| 2023-05-24 | Walter Blane Director | Grant or award | +83,054 | 93,454 | ||
| 2023-05-24 | Walter Blane Director | Grant or award · Stock Option (Right to Buy) | +284,865 | 284,865 | ||
| 2023-02-14 | Favit-Van Pelt Antonella R. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +1,463,000 | 1,463,000 | ||
| 2023-02-14 | MATHIESEN JEFFREY S CFO and Treasurer | Grant or award · Stock Option (Right to Buy) | +2,693,000 | 2,693,000 | ||
| 2023-02-14 | ANDREEFF DANE President and CEO | Grant or award · Stock Option (Right to Buy) | +5,181,000 | 5,181,000 |
Page 4 of 11 · 203 trades